Related content

Direct-to-consumer pharmacogenomic testing

By Howard Heidi Carmen   Borry Pascal  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1367-1370

Future Medicine

Access to resources Recommend Favorite

Beyond the clinic: ‘direct-to-consumer’ genomic profiling services and pharmacogenomics

By Prainsack Barbara   Vayena Effy  

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 403-412

Future Medicine

Access to resources Recommend Favorite

Predictive ability of direct-to-consumer pharmacogenetic testing: when is lack of evidence really lack of evidence?

By Kalf Rachel RJ   Bakker Rachel   Janssens A Cecile JW  

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 341-344

Future Medicine

Access to resources Recommend Favorite

Costs and Benefits of Direct-to-Consumer Advertising: The Case of Depression

By Block Adam E.  

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 511-521

Adis International

Access to resources Recommend Favorite

Direct-to-consumer ads may be beneficial for aromatase inhibitors

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 668, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite